The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.


Virtual Press Room


The Virtual Press Room is a courtesy for corporate and institutional public relations professionals. Publication of material on this page does not constitute an endorsement by ASCO of any product or claim.

For information about how to submit a press release to the Virtual Press Room, click here.

2012 ASCO ANNUAL MEETING

Amgen
AMGEN’S BiTE® ANTIBODY BLINATUMOMAB (AMG 103) ACHIEVED HIGH RATE OF COMPLETE RESPONSE IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

ANALYSIS OF RILOTUMUMAB (AMG 102) DATA IDENTIFIES A POTENTIAL PREDICTIVE BIOMARKER FOR PATIENTS WITH GASTRIC OR GASTROESOPHAGEAL CANCER

AVEO Oncology
AVEO and Astellas Announce Positive Findings from TIVO-1 Superiority Study of Tivozanib in First Line Advanced RCC

Dendreon
Dendreon Announces Presentation of PROVENGE Data at the ASCO 2012 Annual Meeting

Fox Chase Cancer Center
Fox Chase Researchers Find No Disparities in Imaging before Breast Cancer Surgery

More Cutting-Edge Cancer Research Supported by Industry

Georgetown Lombardi Comprehensive Cancer Center
Study Combines Lapatinib with Cetuximab to Overcome Resistance in EGFR-driven Tumors

Phase I Study of Temsirolimus, Capecitabine Proves Safe; Positive Survival Trend Seen

MD Anderson Cancer Center
Hybrid vaccine demonstrates potential to prevent breast cancer recurrence

Memorial Sloan-Kettering Cancer Center
Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps Personalize Treatment

The Mount Sinai Medical Center
Late Stage and HPV-Positive Cancer Treatment Trends, Multiple Myeloma Vaccine, Predictors of Cancer Survival and Staging Among Research Presented by Mount Sinai at American Society of Clinical Oncology Meeting

The Ohio State University
EXPERIMENTAL AGENT MAY HELP OLDER PEOPLE WITH CHRONIC LEUKEMIA - 6507

REVISED GLIOBLASTOMA CLASSIFICATION SHOULD IMPROVE PATIENT CARE

Thomas Jefferson University
Younger Colon Cancer Patients Have Worse Prognosis at Diagnosis, Yet Better Survival


 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005–2012 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.
Feedback Form